Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 52 Insulin Resistance 12 Metabolic Syndrome 4 Hyperandrogenism 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Obesity 3 Breast Neoplasms 3 Weight Loss 2 Rare Diseases 2 Infertility, Female 2 Hyperinsulinism 2 Endocrine System Diseases 2 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Premature Birth 1 Obesity, Morbid 1 Metformin 1 Menstruation Disturbances 1 Inflammation 1 Infertility 1 Hyperglycemia 1 Head and Neck Neoplasms 1 Glucose Intolerance 1 Endometrial Neoplasms 1 Diabetes Mellitus 1 Depression 1

Interventions

Exercise 4 Resistance Training 3 Probiotics 2 Endurance Training 2 Dexmedetomidine 2 falcarinol 1 falcarindiol 1 Vitamin D 1 Tea 1 Selenium 1 Saline Solution 1 Reperfusion 1 Qigong 1 Platelet Count 1 Plastic Surgery Procedures 1 Nutrition Assessment 1 Morphine 1 Mindfulness 1 Methods 1 Metformin 1 Massage 1 Lidocaine 1 Ischemic Preconditioning 1 Inositol 1 Ibuprofen 1 Hyperspectral Imaging 1 High-Intensity Interval Training 1 Folic Acid 1 Fish Oils 1 Diet, Mediterranean 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Inflammation × Metformin × Clear all

NCT02302326 2020-02-26

PI12/1984

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Phase NA Completed

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡